Procainamide-induced systemic lupus erythematosus.
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D000888:Antibodies, Anti-Idiotypic; D000974:Antibodies, Antinuclear / Q000032:analysis; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001799:Blood Sedimentation; D006801:Humans; D007074:Immunoglobulin G; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D009504:Neutrophils; D011342:Procainamide / Q000009:adverse effects*
D000888:Antibodies, Anti-Idiotypic; D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D011342:Procainamide